E 6130 manufacturers
- E6130
-
- $3128.00
-
2026-05-11
- CAS:1427058-33-0
- Purity:
- Supply Ability: 10g
- E6130
-
- $3128.00
-
2025-08-22
- CAS:1427058-33-0
- Purity:
- Supply Ability: 10g
|
| Product Name: | E 6130 | | Synonyms: | E 6130;3-Pyrrolidineacetic acid, 1-[[2-chloro-6-(trifluoromethyl)phenyl]methyl]-3-[[[1-(1-cyclohexen-1-ylmethyl)-4-piperidinyl]amino]carbonyl]-4-methyl-, (3S,4R)-;E-6130,E6130 | | CAS: | 1427058-33-0 | | MF: | C28H37ClF3N3O3 | | MW: | 556.06 | | EINECS: | | | Product Categories: | | | Mol File: | 1427058-33-0.mol |  |
| | E 6130 Chemical Properties |
| Boiling point | 649.2±55.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: ≥ 250 mg/mL (449.59 mM) | | pka | 4.43±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | E 6130 Usage And Synthesis |
| Uses | E6130 is an orally active and highly selective CX3CR1 modulator, that may be effective for treatment of inflammatory bowel disease. | | in vivo | E6130 (10 or 30 mg/kg, p.o.) reduces several inflammatory bowel disease-related parameters in a murine CD4+ CD45RBhigh T-cell-transfer colitis model and a murine oxazolone-induced colitis model[1]. | | References | [1] Wakita H, et al. E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis. Mol Pharmacol. 2017 Nov;92(5):502-509. DOI:10.1124/mol.117.108381 |
| | E 6130 Preparation Products And Raw materials |
|